FLOW CYTOMETRY, CD 5

The Flow Cytometry CD5 Test is a specialized immunophenotyping assay used to detect and measure the expression of CD5, a cell surface glycoprotein primarily found on T lymphocytes and a small subset of normal B lymphocytes. CD5 plays an important role in immune cell signaling and regulation and is widely used in hematology for diagnosing and classifying lymphoid malignancies.

Flow cytometry technology enables rapid analysis of thousands of cells individually, helping identify CD5-positive cell populations and evaluate their immunophenotypic characteristics. CD5 is routinely included in comprehensive flow cytometry panels used for investigating leukemias, lymphomas, lymphoproliferative disorders, and immune system abnormalities.

While CD5 is normally expressed on T cells, abnormal expression on B cells is particularly important in diagnosing certain B-cell malignancies. The presence of CD5-positive B-cell populations can help distinguish specific disorders such as Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) from other B-cell neoplasms.

Benefits of the Test

• Identifies T-cell and abnormal B-cell populations
• Assists in leukemia and lymphoma diagnosis
• Supports classification of lymphoid malignancies
• Helps evaluate lymphoproliferative disorders
• Assists disease monitoring and follow-up
• Provides valuable immunophenotypic information

Why Doctors Recommend This Test

Doctors may recommend Flow Cytometry CD5 testing for:

• Suspected Chronic Lymphocytic Leukemia (CLL)
• Mantle Cell Lymphoma evaluation
• T-cell leukemia investigation
• T-cell lymphoma assessment
• Persistent lymphocytosis
• Abnormal blood counts
• Bone marrow disorder evaluation
• Comprehensive leukemia and lymphoma immunophenotyping

The test helps characterize abnormal lymphocyte populations and contributes to accurate disease classification.

Preparation Before Test

The test may require:

• Peripheral blood sample
• Bone marrow aspirate
• Lymph node tissue
• Body fluid specimen
• Other clinically relevant samples

Preparation generally includes:

• No fasting is required
• Inform your physician about current treatments
• Follow laboratory collection instructions

The specimen is analyzed using advanced multiparameter flow cytometry technology.

Normal Reporting Time

Results are generally available within 1 to 3 working days, depending on laboratory workflow and panel complexity.

Who Should Take This Test?

• Patients with suspected leukemia
• Individuals with suspected lymphoma
• Patients with abnormal lymphocyte counts
• Individuals with persistent lymphocytosis
• Patients undergoing bone marrow evaluation
• Individuals referred by hematologists or oncologists

Flow Cytometry CD5 testing is an important component of modern hematological diagnostics and lymphoid malignancy evaluation.

Clinical Significance

CD5 expression may be observed in:

• Normal T Lymphocytes
• Chronic Lymphocytic Leukemia (CLL)
• Small Lymphocytic Lymphoma (SLL)
• Mantle Cell Lymphoma (MCL)
• T-cell Acute Lymphoblastic Leukemia (T-ALL)
• Peripheral T-cell Lymphomas
• Other Lymphoproliferative Disorders

Abnormal CD5-positive B-cell populations are particularly useful in differentiating specific B-cell malignancies from other lymphoid disorders.

Important Note

CD5 is interpreted alongside additional markers such as CD19, CD20, CD22, CD23, CD3, CD4, CD8, CD45, Kappa Light Chains, and Lambda Light Chains. Accurate diagnosis requires comprehensive immunophenotypic analysis by a hematopathologist.